Heidelberg Pharma Research

Heidelberg Pharma Research is owned by Heidelberg Pharma.

View the org chart displaying its 2 main executives

Most searched biographies at Heidelberg Pharma Research

• Jan Schmidt-Brand, Chief Executive Officer
• Andreas Pahl, Chief Scientific Officer

Popular executive movements at Heidelberg Pharma

• Jan Schmidt-Brand, Chief Executive Officer and Managing Director of Pharma Research, will retire on Feb. 1, 2024  (posted on November 30 2023).
• Andreas Pahl who is Member of the Management Board and Chief Scientific Officer, will be promoted to Chief Executive Officer and Managing Director of Pharma Research on Feb. 1, 2024  (posted on November 30 2023).

Create your alert
to follow the executive moves at Heidelberg Pharma Research.

Heidelberg Pharma has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Heidelberg Pharma Research

Social media about Heidelberg Pharma Research

• Heidelberg Pharma Research on Wikipedia, Google News & Yahoo Finance
• Heidelberg Pharma Research on LinkedIn, Twitter & YouTube

Call Heidelberg Pharma Research at +49 62...

View the org chart

Register to receive your alert

Report an error